Who founded Outrun Therapeutics?

Outrun Therapeutics was founded by Satpal Virdee.

Who are Outrun Therapeutics's investors?

Outrun Therapeutics's investors include M Ventures, MC Healthcare Ventures, Diamond Edge Ventures.

Where is Outrun Therapeutics headquartered?

Outrun Therapeutics is headquartered in Dundee, GB.

Outrun Therapeutics

Dundee, GB · 10 employees on LinkedIn · 3 known investors

Find your way into Outrun Therapeutics

Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases. Its lead programme targets an E3 ligase in hard-to-treat solid tumours.

Biotech Deep Tech

Founders & leadership

Satpal VirdeeFounder

Investors · 3

M VenturesLos Angeles · $10.8M

MC Healthcare VenturesCambridge

Diamond Edge VenturesreportedSan Francisco

Funding

SEC filings, press & company announcements

Undisclosed amountSeedApr 2024
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗

Registered name: OUTRUN THERAPEUTICS LIMITED
Company number: SC648164
Status: Active
Company type: Private limited company
Incorporated: 26 Nov 2019
Registered office: Errol Road, Invergowrie, Dundee, DD2 5DA
Nature of business (SIC): 86900 — Other human health activities
Accounts: last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement: last made up to 12 Mar 2026 · next due 26 Mar 2027

Current officers · 4

Bauke Anninga — director, appointed 27 Nov 2023
Anthony Gerard Johnson — director, appointed 23 Sept 2022
Christopher Roberts — director, appointed 14 Jul 2021
Satpal Singh Virdee — director, appointed 24 Nov 2020

Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Outrun Therapeutics Raises $10M in Seed Financingfinsmes.com · Apr 2024

Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipelinestreetinsider.com

Frequently asked questions

What does Outrun Therapeutics do?: Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases. Its lead programme targets an E3 ligase in hard-to-treat solid tumours.
Who founded Outrun Therapeutics?: Outrun Therapeutics was founded by Satpal Virdee.
Who are Outrun Therapeutics's investors?: Outrun Therapeutics's investors include M Ventures, MC Healthcare Ventures, Diamond Edge Ventures.
Where is Outrun Therapeutics headquartered?: Outrun Therapeutics is headquartered in Dundee, GB.